Vasiliy V Polosukhin Selected Research

Vasiliy V Polosukhin Research Topics

Disease

20	Inflammation (Inflammations) 01/2022 - 04/2006
13	Fibrosis (Cirrhosis) 01/2022 - 01/2005
12	Pneumonia (Pneumonitis) 04/2016 - 11/2005
9	Neoplasms (Cancer) 01/2022 - 03/2007
9	Chronic Obstructive Pulmonary Disease (COPD) 11/2021 - 08/2011
8	Carcinogenesis 01/2022 - 03/2007
6	Asthma (Bronchial Asthma) 01/2022 - 12/2009
5	Lung Injury 02/2016 - 04/2006
5	Hyperplasia 12/2011 - 12/2009
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 04/2005
4	Emphysema 01/2021 - 04/2016
4	Respiratory Hypersensitivity 10/2018 - 05/2009
4	Airway Remodeling 01/2018 - 05/2010
4	Hypoxia (Hypoxemia) 12/2015 - 05/2007
3	Lung Neoplasms (Lung Cancer) 12/2019 - 11/2007
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2008
2	Hypertrophy 12/2021 - 05/2010
2	Sarcoidosis (Schaumann Disease) 01/2016 - 09/2014
2	Infections 06/2012 - 05/2009
2	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2012 - 06/2011
2	Idiopathic Pulmonary Fibrosis 10/2010 - 04/2010
2	Lung Diseases (Lung Disease) 05/2010 - 05/2007
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2008 - 11/2007
2	Acute Lung Injury 10/2007 - 04/2006
1	Adenocarcinoma of Lung 01/2022
1	Radiation Fibrosis Syndrome (Radiation Fibrosis) 01/2022
1	Tertiary Lymphoid Structures 01/2021
1	Necrosis 01/2021
1	Lewis Lung Carcinoma 12/2019
1	Disease Progression 04/2016

Drug/Important Bio-Agent (IBA)

14	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 01/2005
11	Proteins (Proteins, Gene)FDA Link 12/2019 - 05/2007
10	CollagenIBA 12/2021 - 01/2005
7	CytokinesIBA 01/2021 - 05/2007
6	Secretory Immunoglobulin A (SIgA)IBA 01/2021 - 08/2011
6	NF-kappa B (NF-kB)IBA 12/2009 - 04/2006
5	Urethane (Ethyl Carbamate)IBA 12/2019 - 11/2007
4	Interleukin-13IBA 01/2022 - 05/2009
4	Polymeric Immunoglobulin Receptors (Polymeric Immunoglobulin Receptor)IBA 11/2018 - 08/2011
4	Surface-Active Agents (Surfactants)IBA 06/2011 - 11/2005
3	AllergensIBA 01/2021 - 12/2009
3	Doxycycline (Periostat)FDA LinkGeneric 01/2018 - 05/2007
3	LipopolysaccharidesIBA 02/2016 - 05/2013
3	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2012 - 06/2011
3	Protein CIBA 06/2011 - 11/2005
2	Interleukin-4 (Interleukin 4)IBA 01/2022 - 05/2010
2	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 10/2018
2	LigandsIBA 01/2022 - 01/2022
2	Interleukin-5 (Interleukin 5)IBA 01/2022 - 01/2021
2	IntegrinsIBA 01/2022 - 01/2020
2	CarcinogensIBA 01/2022 - 01/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 12/2015
2	Interleukin-33IBA 01/2022 - 01/2021
2	AntigensIBA 01/2021 - 08/2011
2	Interleukin-17 (Interleukin 17)IBA 10/2018 - 06/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 01/2016
2	AntibodiesIBA 01/2018 - 12/2015
2	MucinsIBA 12/2015 - 05/2009
2	Clodronic Acid (Clodronate)IBA 12/2014 - 12/2011
2	X-Box Binding Protein 1IBA 06/2012 - 06/2011
2	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 04/2012 - 06/2011
2	Messenger RNA (mRNA)IBA 06/2011 - 05/2010
2	Carbonic Anhydrase IXIBA 06/2011 - 10/2007
2	I-kappa B KinaseIBA 05/2007 - 04/2006
1	ifetrobanIBA 01/2022
1	ThromboxanesIBA 01/2022
1	AgarIBA 01/2022
1	AndrogensIBA 01/2022
1	Dehydroepiandrosterone (DHEA)IBA 01/2022
1	Arachidonic Acid (Vitamin F)IBA 01/2022
1	F2-Isoprostanes (F2 Isoprostanes)IBA 01/2022
1	ProstaglandinsIBA 01/2022
1	4,4',4''- (4- propyl- ((1)H)- pyrazole- 1,3,5- triyl) tris-phenolIBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Estrogens (Estrogen)FDA Link 01/2021
1	NAD (NADH)IBA 01/2021
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021
1	CCR2 ReceptorsIBA 01/2020
1	Vitamin K FDA Link 12/2019
1	GSK 1363089IBA 12/2019
1	Warfarin (Coumadin)FDA LinkGeneric 12/2019
1	c-Mer Tyrosine KinaseIBA 12/2019
1	Interleukin-15 (Interleukin 15)IBA 11/2018
1	Interleukin-15 Receptors (Interleukin 15 Receptor)IBA 11/2018
1	SmokeIBA 11/2018
1	Hormones (Hormone)IBA 10/2018
1	Immunoglobulin E (IgE)IBA 10/2018
1	Testosterone (Sustanon)FDA Link 10/2018
1	salicylhydroxamic acid (SHAM)IBA 10/2018
1	Tyrosine Kinase InhibitorsIBA 06/2016
1	ErbB Receptors (EGF Receptor)IBA 06/2016
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 04/2016
1	RoflumilastIBA 04/2016
1	Leukocyte Elastase (Neutrophil Elastase)IBA 04/2016
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2016
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2016
1	Peroxidase (Myeloperoxidase)IBA 01/2016

Therapy/Procedure

3	Therapeutics 01/2022 - 06/2013